Completed PHASE3 INTERVENTIONAL 4-arm NCT04365270

Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer

The Antimicrobial Activity and Clinical Performance of Chitosan-modified Glass Ionomer: A Randomized Clinical Trial

Sponsor: Ain Shams University

Conditions Caries Caries Class I Caries,Dental Caries; Dentin Pulpitis Reversible Pulpitis

Interventions Chitosan Low Molecular Weight (20-200 Mpa.S) Chlorhexidine Diacetate Glass Ionomer Titanium Dioxide

Updated 6 times since 2020 Last updated: Jan 11, 2021 Started: Jan 15, 2019 Primary completion: Jan 5, 2021 Completion: Jan 5, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Caries and Caries Class I and is currently completed. Ain Shams University leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Feb 2021 — Jul 2024 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting PHASE3
Aug 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

▶ Show 1 earlier version

May 2020 — Aug 2020 [monthly]

Active Not Recruiting PHASE3

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt